5.950USD-1.33%Mkt Cap: 26.84M $P/E: —1d ago
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offer…
Industry Peers
Medical Instruments & Supplies$142.49BUSDP/E 48.8
$83.33BUSDP/E 33.5
$73.25BUSDP/E 36.1
$44.07BUSDP/E 27.9
$31.56BUSDP/E 42.0
$29.41BUSDP/E 19.6
$25.61BUSDP/E 48.5
$19.64BUSDP/E 67.5
$18.05BUSDP/E 44.5
$18.27BUSDP/E 103.6
$14.52BUSDP/E 81.9
$13.88BUSDP/E 45.2
$14.26BUSDP/E 61.9
$14.15BUSDP/E 10.0
$12.78BUSDP/E 30.0
$12.06BUSD
$8.60BUSDP/E 23.1
$8.38BUSDP/E 165.1
$7.69BUSD
$5.67BUSDP/E 23.2
$5.99BUSDP/E 1931.7
$4.61BUSDP/E 31.0
$4.51BUSDP/E 32.6
$4.46BUSD
$4.39BUSDP/E 65.8
$4.00BUSDP/E 40.2
$4.05BUSDP/E 87.2
$3.63BUSDP/E 16.3
$3.36BUSDP/E 21.6
$3.39BUSDP/E 2759.0
$2.79BUSDP/E 21.4
$2.60BUSD
$2.77BUSD
$2.35BUSDP/E 37.9
$1.88BUSDP/E 33.0
$1.89BUSD
$1.80BUSD
$1.48BUSD
$1.44BUSD
$1.41BUSD
$1.25BUSDP/E 62.5
$1.23BUSD
$1.09BUSD
$745.86MUSDP/E 15.9
$811.83MUSD
$761.22MUSDP/E 14.9
$675.68MUSDP/E 39.4
$659.76MUSDP/E 55.8
$584.44MUSD
$354.63MUSDP/E 20.8
$350.60MUSDP/E 16.9
$272.64MUSD
$244.96MUSDP/E 13.5
$232.03MUSDP/E 422.0
$228.42MUSDP/E 21.2
$207.13MUSDP/E 34.9
$198.25MUSDP/E 23.8
$198.75MUSDP/E 1.8
$194.76MUSD
$188.63MUSDP/E 16.3
$164.06MUSD
$151.41MUSD
$121.82MUSDP/E 38.7
$115.11MUSD
$120.22MUSD
$106.20MUSD
$61.36MUSDP/E 6.4
$59.94MUSD
$48.70MUSD
$40.82MUSDP/E 53.7
$41.23MUSDP/E 41.0
$37.15MUSD
$32.66MUSD
$25.49MUSDP/E 177.7
$20.69MUSD
$15.94MUSD
$14.75MUSD
$14.55MUSD
$13.43MUSD
$9.21MUSD
$8.63MUSDP/E 14.8
$7.46MUSD
$5.07MUSD
$4.00MUSD
$465.9KUSD
$138.6KUSD
Indicators:|
Key Statistics
Company
Market Cap26.84M $
Enterprise Value63.86M $
Revenue (TTM)85.53M $
Gross Profit49.91M $
Net Income (TTM)-56.70M $
Revenue/Share19.20 USD
Last Price5.950 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees316
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS4169061052
Valuation
P/E (Trailing)—
P/E (Forward)13.52
PEG1.31
EV/EBITDA8.16
EV/Revenue0.75
P/S0.31
P/B2.67
EPS (TTM)-2.15
EPS (Forward)0.44
52W Range
3.80038% of range9.400
52W High9.400 USD
52W Low3.800 USD
Profitability
Gross Margin57.67%
Oper. Margin-4.52%
EBITDA Margin9.15%
Profit Margin-65.51%
ROE-412.84%
ROA-70.81%
Growth
Revenue Growth-4.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF6.73M $
CapEx (TTM)1.86M $
FCF Margin9.17%
FCF Yield29.23%
Net Debt37.02M $
Net Debt/EBITDA4.73
Balance Sheet
Debt/Equity3.22
Current Ratio1.99
Quick Ratio0.91
Book Value/Sh2.227 USD
Cash/Share1.574 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateMar 16, 2026
Analyst Consensus
Rating—
Target (Mean)6.000 USD
Upside (mean)+0.8%
Target Range6.000 USD – 6.000 USD
# Analysts1
Ownership
Shares Out.4.51M
Float3.51M
Insiders9.48%
Institutions41.46%
Short Interest
Short Ratio3.2d
Short % Float1.60%
Short % Out.1.57%
Shares Short70.89K
Short (prev mo.)106.20K
Technical
SMA 506.070 (-2.0%)
SMA 2005.834 (+2.0%)
Beta1.50
S&P 52W Chg20.25%
Avg Vol (30d)16.97K
Avg Vol (10d)12.98K
Technical Indicators
RSI (14)46.3
MACD0.0028
MACD Signal0.0321
MACD Hist.-0.0293
BB Upper6.429 USD
BB Middle6.091 USD
BB Lower5.753 USD
BB Width11.11%
ATR (14)0.3165 USD
Vol Ratio (20d)0.74x